nafimidone has been researched along with Aura in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avci, A; Barut, B; Koçak Aslan, E; Marcinkowska, M; Özel, A; Sabuncuoğlu, S; Sari, S; Siwek, A | 1 |
| Gunawan, S; Treiman, DM | 1 |
2 other study(ies) available for nafimidone and Aura
| Article | Year |
|---|---|
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Epilepsy; Mice; Molecular Docking Simulation; Morbidity; Naphazoline | 2022 |
Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy.
Topics: Adult; Anticonvulsants; Chronic Disease; Epilepsy; Female; Half-Life; Humans; Imidazoles; Kinetics; Male; Middle Aged; Naphazoline | 1987 |